Find AMR Resources
Connecting the AMR community with the solutions it needs
The tools advancing the AMR response are as diverse as the problem itself, spanning contract services, diagnostics, surveillance platforms, infection prevention technologies, digital technologies, and beyond. This growing directory brings them together in one place, making it easier for researchers, clinicians, investors, and advocates to find, evaluate, and connect with the solutions the global AMR fight needs.
CC4CARB , the Chemistry Center for Combating Antibiotic Resistant Bacteria , is a US-based initiative operated by RTI International that synthesizes and delivers focused chemical libraries to the global scientific community for Gram-negative antibacterial drug discovery. Its compound collection is designed specifically to support high-throughput screening and rational drug design targeting the most dangerous drug-resistant Gram-negative pathogens.
Cellexus is a Dundee-based manufacturer of single-use airlift bioreactors designed for cell culture and fermentation processes. Its CellMaker platform supports the scale-up manufacturing of biologics , including bacteriophages, vaccines, and antimicrobial proteins , providing cost-effective, contamination-resistant production systems for AMR innovators developing phage therapies and next-generation biologic anti-infectives that require scalable, aseptic manufacturing infrastructure.
C-CAMP is a Bengaluru-based innovation hub of the Department of Biotechnology, Government of India, providing shared research infrastructure, technology platforms, and entrepreneurship support for life sciences startups and researchers. It incubates early-stage biotech companies , including in infectious disease and AMR diagnostics , and facilitates translation of scientific discoveries into commercially viable products.
Citrox Biosciences is a London-based company developing plant-derived antipathogenic solutions for healthcare, consumer, and institutional applications. Its Citrox technology , based on bioflavonoids extracted from citrus fruits , provides broad-spectrum antimicrobial activity against bacteria, viruses, and fungi without contributing to resistance development, offering a non-antibiotic infection prevention tool for wound care, surface disinfection, and clinical hygiene.
Clover Bioanalytical Software is a Spanish bioinformatics company providing the first cloud-based AI platform for MALDI-TOF mass spectrometry data analysis and strain typing. Its software enables clinical microbiology labs to perform rapid bacterial identification and AMR strain typing directly from MALDI-TOF and FTIR spectral data , accelerating diagnostic workflows and outbreak investigation in hospital and public health settings.
CodiKoat is a Middlesbrough-based company developing antimicrobial coating technologies for medical devices and healthcare surfaces. Its coatings use novel chemistry to prevent bacterial colonization on catheters, implants, and clinical surfaces , targeting healthcare-associated infections caused by drug-resistant organisms including MRSA and Gram-negative pathogens, offering a preventive approach that reduces the need for antibiotic treatment.
CDD Vault is a powerful yet intuitive informatics software platform designed to manage, analyze, and share scientific data across discovery teams. Built for usability and scientific depth, it empowers researchers to centralize experimental results, chemical or biological entities, and workflows in a secure, cloud-based environment accessible from any browser.
The Spanish National Research Council (CSIC) is Spain\'s largest public research institution, conducting fundamental and applied research across science and technology including microbiology, infectious disease, and antimicrobial drug discovery. With over 120 research institutes and more than 11,000 researchers, CSIC is a major contributor to European AMR science , investigating resistance mechanisms, novel antimicrobial compounds, and diagnostics across bacterial and fungal pathogens.
CrisprBits is a Bengaluru-based biotechnology company applying CRISPR-Cas gene editing technology to antimicrobial applications, including the development of CRISPR-based antimicrobials and diagnostic tools for drug-resistant pathogens. Its platform exploits CRISPR\'s precision targeting to develop novel therapeutic and diagnostic applications that specifically identify or eliminate resistant bacterial strains, addressing AMR through molecular approaches distinct from conventional antibiotics.
The Unyvero A50 System is a syndromic testing platform for fast diagnosis of severe infectious diseases. The system uses powerful multiplex PCR technology to detect a wide variety of microorganisms and antibiotic resistance markers within 4-5 hours
Cytecom is a Leeds-based biotechnology company developing novel anti-biofilm and antimicrobial compounds for treatment of drug-resistant infections associated with medical devices and implants. Biofilm-associated infections are among the most resistant clinical challenges , conventional antibiotics are largely ineffective against established biofilms. Cytecom\'s compounds target the biofilm matrix directly, disrupting resistant bacterial communities in catheter, joint replacement, and implant-related infections.
Day Zero Diagnostics is a Boston-based infectious disease diagnostics company, acquired by bioMérieux in 2025. Its whole-genome sequencing platform identifies both the infecting pathogen and its full antibiotic resistance profile directly from clinical samples in hours , bypassing culture-based methods that take days, enabling physicians to prescribe the right antibiotic from the first day of hospital admission.
Delft Enterprises is the technology transfer and commercialization company of Delft University of Technology, translating TU Delft research into commercial ventures. It has supported the spinout of innovative companies working across materials science, biotech, and engineering , including technologies with applications in infection prevention and antimicrobial surface coatings , facilitating the commercial development of academic innovations relevant to AMR.
Destiny Pharma is a Brighton-based clinical-stage biotechnology company developing novel infection prevention medicines. Its lead programs include XF-73 nasal gel for prevention of post-surgical staphylococcal infections including MRSA, and NTCD-M3, a biotherapeutic for preventing recurrent C. difficile infections. In 2024, the company entered administration after failing to secure a licensing partner for its lead candidate.
Diagopreutic is a Visakhapatnam, India–based company developing integrated diagnostic and therapeutic solutions for infectious diseases and AMR. Operating at the intersection of diagnostics and treatment, the company focuses on developing accessible, affordable tools for pathogen detection and resistance profiling in Indian healthcare settings , where AMR burden is among the highest globally and access to clinical microbiology infrastructure remains severely limited.
Disperazol, developed by Copenhagen-based Biophys Ltd, is a novel antifungal agent targeting drug-resistant Candida and other fungal pathogens. It uses a unique mechanism based on disrupting fungal biofilms rather than fungal cell structure , an approach designed to circumvent the resistance pathways that are making existing azole and echinocandin antifungals progressively less effective against serious fungal infections.
Dispocare is the exclusive Dutch distributor of Hygie hygiene products for healthcare settings, supplying disposable collection bags, bedpans, urinals, and emesis basins designed to support infection prevention in clinical and care environments. Their products reduce manual handling of bodily waste, lowering infection transmission risk in hospitals, nursing homes, and home care.
éclateral is a Cambridge-based strategic consulting firm specializing in the life sciences and pharmaceutical sectors. It provides market access, commercial strategy, and policy advisory services , including for AMR-focused companies navigating the complex regulatory and commercial challenges of bringing new antibiotics and diagnostics to market in a structurally broken commercial environment.
EIT Health is a European Union–backed network of leading health innovators, connecting academia, industry, and healthcare institutions across Europe. It funds and accelerates health innovation , including AMR solutions , through education programs, startup incubation, investment support, and cross-sector collaboration, enabling the translation of scientific discoveries into products and services that improve patient outcomes.
EMPE Diagnostics is a Lund, Sweden–based molecular diagnostics company developing rapid tests for tuberculosis, MDR-TB, and antimicrobial resistance using innovative Pli-RCA, qPCR, and lateral flow technologies. Its diagnostics are designed for global healthcare markets , including high-burden low-income settings , providing fast, affordable TB resistance detection to guide treatment decisions and prevent the spread of drug-resistant tuberculosis.
Stay connected so that you don't miss the latest AMR insights and updates.
